ROCIO ARGUETA: Open Payments
NPI 1396053369 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 58 payments from 15 companies in 2025. Trend: 2023 $1,374 · 2024 $1,181 · 2025 $1,487
Food & beverage: $1,388Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $356 |
| GlaxoSmithKline, LLC. | 14 | $231 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $183 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 |
| Astellas Pharma US Inc | 1 | $99 |
| Biogen, Inc. | 1 | $84 |
| Lundbeck LLC | 4 | $75 |
| ABBVIE INC. | 3 | $73 |
| Lilly USA, LLC | 1 | $70 |
| Electromed, Inc. | 2 | $67 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, REXULTI, JARDIANCE, ZURZUVAE, BREZTRI, SMARTVEST, ZENPEP.
Industry payments across CA — which companies pay providers there.
